title: Does hypercholesterolemia affect the relaxation of the detrusor smooth muscle in rats? In vitro and in vivo studies.
abstract: To evaluate the effects of hypercholesterolemia on the relaxation function of the urinary bladder, we examined the physiological mechanisms involved in the isoproterenol-induced relaxation in isolated detrusor strips in vitro and voiding behavior in vivo in rats. Adult male Sprague-Dawley rats were fed standard (control, N = 16) or 4 % cholesterol diet (hypercholesterolemia, N = 17) for 4 weeks. Concentration-response curves for isoproterenol-induced relaxations in carbachol-precontracted detrusor muscle strips were recorded. The contributions of β2- and β3-adrenoceptors and ATP-dependent and Ca(2+)-dependent potassium channels to the relaxation response were investigated by using selective adrenergic agonists salbutamol and BRL 37344 and specific potassium channel inhibitors glibenclamide and charybdotoxin, respectively. Cystometrography was performed to assess bladder function. Hypercholesterolemic rats had higher serum cholesterol and low- and high-density lipoprotein levels than the controls with no sign of atherosclerosis. Isoproterenol-induced relaxation was significantly enhanced in the hypercholesterolemia group. Preincubation with the M2 receptor antagonist attenuated the relaxation response in both groups. The relaxation responses to isoproterenol and salbutamol were similar in both groups, while BRL 37344 appeared to produce a greater relaxant effect in the hypercholesterolemic rats. Also, the inhibitory effects of potassium channel inhibitors on relaxation responses were comparable among the groups. The cystometric findings revealed that threshold and basal pressure values were higher in the hypercholesterolemia group compared with controls. We showed that hypercholesterolemia leads to greater relaxation responses to isoproterenol, appears to impair the braking function of M2 cholinergic receptors on adrenoceptor-induced relaxations in the isolated detrusor muscle, and affects the voiding function in rats.
authors.affiliation: Department of Physiology, Faculty of Medicine, Hacettepe University, 39, 06100, Sihhiye, Ankara, Turkey, sbayrak@hacettepe.edu.tr.
authors.forename: Sibel
authors.initials: S
authors.lastname: Bayrak
authors.forename: Zeynep Dicle
authors.initials: ZD
authors.lastname: Balkanci
authors.forename: Bilge
authors.initials: B
authors.lastname: Pehlivanoğlu
authors.forename: İsmail
authors.initials: İ
authors.lastname: Karabulut
authors.forename: Serkan
authors.initials: S
authors.lastname: Karaismailoğlu
authors.forename: Ayşen
authors.initials: A
authors.lastname: Erdem
mesh_terms: D000322:Adrenergic Agonists / Q000494:pharmacology; D000818:Animals; D006937:Hypercholesterolemia / Q000378:metabolism / Q000503:physiopathology*; D066298:In Vitro Techniques; D054086:KATP Channels / Q000378:metabolism; D008055:Lipids / Q000097:blood; D008297:Male; D009126:Muscle Relaxation / Q000187:drug effects / Q000502:physiology*; D009130:Muscle, Smooth / Q000187:drug effects / Q000502:physiology*; D026902:Potassium Channel Blockers / Q000494:pharmacology; D024681:Potassium Channels, Calcium-Activated / Q000378:metabolism; D017207:Rats, Sprague-Dawley; D018343:Receptors, Adrenergic, beta-2 / Q000378:metabolism; D022702:Receptors, Adrenergic, beta-3 / Q000378:metabolism; D001743:Urinary Bladder / Q000187:drug effects / Q000378:metabolism / Q000502:physiology*; D014554:Urination / Q000187:drug effects / Q000502:physiology*
chemical_list: D000322:Adrenergic Agonists; D054086:KATP Channels; D008055:Lipids; D026902:Potassium Channel Blockers; D024681:Potassium Channels, Calcium-Activated; D018343:Receptors, Adrenergic, beta-2; D022702:Receptors, Adrenergic, beta-3